Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
668
datasets available to search
ShareScore release 0.9.0
Dataset results
668 results for “Everolimus”
REsorbable SCaffolds With everolimUs-Elution for the Treatment of Infrapopliteal Artery Disease in Patients With Chronic Limb-threatening Ischemia
ClinicalTrials.gov study NCT07270575. IPD Sharing: NO. Countries: 0. Publications: 1.
Roll-over Study to Collect and Assess Long-term Safety of Everolimus in Patients With TSC and Refractory Seizures Who Have Completed the EXIST-3 Study [CRAD001M2304] and Who Are Benefitting From Conti
ClinicalTrials.gov study NCT02962414. IPD Sharing: UNDECIDED. Countries: 18. Publications: 0.
A Study of Lapatinib in Combination With Everolimus in Patients With Advanced, Triple Negative Breast Cancer
ClinicalTrials.gov study NCT01272141. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to Chemotherapy
ClinicalTrials.gov study NCT00363051. IPD Sharing: Not stated. Countries: 11. Publications: 0.
Akt Inhibitor MK2206 or Everolimus in Treating Patients With Refractory Kidney Cancer
ClinicalTrials.gov study NCT01239342. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
ClinicalTrials.gov study NCT01198158. IPD Sharing: Not stated. Countries: 1. Publications: 0.
XIENCE PRIME Everolimus Eluting Coronary Stent System (EECSS) China Single-Arm Study
ClinicalTrials.gov study NCT01894152. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dose-Finding, Safety and Efficacy Study of RX-0201 Plus Everolimus in Metastatic Renal Cell Cancer
ClinicalTrials.gov study NCT02089334. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Everolimus (RAD001) in Patients With Recurrent Glioblastoma Multiforme (GBM)
ClinicalTrials.gov study NCT00515086. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Efficacy of Oral Everolimus in Patients With Neovascular Age-related Macular Degeneration
ClinicalTrials.gov study NCT00857259. IPD Sharing: Not stated. Countries: 2. Publications: 0.
The Everolimus-Transplant Exit Strategy Trial (E-TEST)
ClinicalTrials.gov study NCT01636466. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pasireotide & Everolimus in Adult Patients With Radioiodine-Refractory Differentiated & Medullary Thyroid Cancer
ClinicalTrials.gov study NCT01270321. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pasireotide (SOM230) With or Without Everolimus in Treating Patients With Hormone Resistant, Chemotherapy Naive Prostate Cancer
ClinicalTrials.gov study NCT01313559. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Everolimus for Cancer With TSC1 or TSC2 Mutation
ClinicalTrials.gov study NCT02201212. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Everolimus (RAD001) as Therapy for Patients With Systemic Mastocytosis
ClinicalTrials.gov study NCT00449748. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma (TSC-AML)
ClinicalTrials.gov study NCT05252585. IPD Sharing: YES. Countries: 1. Publications: 0.
Once-a-day Regimen With Everolimus, Low Dose Cyclosporine and Steroids in Comparison With Steroid Withdrawal or Twice a Day Regimen With Everolimus, Low Dose Cyclosporine and Steroids.
ClinicalTrials.gov study NCT01023815. IPD Sharing: Not stated. Countries: 1. Publications: 0.
To Evaluate the Performance and Safety of RisoR Crest Everolimus Eluting Coronary Stent System
ClinicalTrials.gov study NCT07098195. IPD Sharing: NO. Countries: 0. Publications: 16.
Everolimus in Treating Patients With Previously Treated Unresectable or Metastatic Esophageal Cancer or Stomach Cancer
ClinicalTrials.gov study NCT00985192. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Biomarkers Predicting Successful Tacrolimus Withdrawal and Everolimus (Zortress) Monotherapy Early After Liver Transplantation
ClinicalTrials.gov study NCT02736227. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.